Dosing
Where to inject semaglutide: approved sites and technique
The best site is an approved location where you can follow the device instructions reliably. Ozempic and Wegovy list the abdomen, thigh, and upper arm for subcutaneous injection.
Choosing among approved locations
The abdomen, thigh, and upper arm are labeled injection locations. Choose a site you can safely reach and inspect. An upper-arm injection may require another person's help depending on the device and technique. Follow the supplied Instructions for Use for the exact placement and any required distance from the navel.
Do not inject into a vein or muscle, use an irritated or damaged area, or choose a site because a social-media anecdote promises stronger appetite suppression. The labels allow the approved sites; they do not direct everyone to the abdomen for better weight loss.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information
Rotate spots and keep the routine clear
Rotation means choosing a different spot, even if you continue using the same general body area. Record the day and location if that helps prevent repeating the same spot or accidentally taking an extra dose.
If you also inject insulin, keep the injections separate and follow both medicines' instructions. Do not mix medicines together. Sharing a multidose pen is unsafe even if a new needle is used. Check the solution and product condition according to the device guidance before use.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information
Check the exact product and device
Weekly semaglutide and tirzepatide medicines are injected under the skin, not into a vein or muscle. Approved pens, prefilled syringes, and vials have presentation-specific Instructions for Use. The supplied device determines preparation, injection steps, and what to do if delivery is uncertain.
A compounded vial needs pharmacy-specific concentration and syringe instructions. Milligrams, milliliters, and syringe units are different measures. Do not copy a branded pen technique or another patient's syringe markings. Ask for training whenever the product or presentation changes.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information · Mounjaro prescribing information · Zepbound prescribing information · FDA concerns with unapproved GLP-1 drugs used for weight loss
When technique or delivery is uncertain
If liquid leaks, a device malfunctions, or you cannot tell whether the full dose was delivered, ask the pharmacist or prescriber how to proceed. Repeating a dose without guidance can create an overdose risk. Keep the device and packaging information available for the conversation.
Changing the site does not substitute for care when nausea, abdominal pain, or other symptoms persist. Report significant skin reactions, severe pain, or infection concerns. A clinician can review the injection technique and the symptoms separately.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information
Choose a site by reach, visibility, and device instructions
The abdomen may be easy to see and reach, the thigh may be convenient while seated, and the upper arm may require assistance. Those practical differences can help someone perform the labeled technique reliably. They do not establish that one area produces better weight loss. Follow the device's diagrams and restrictions for the exact location, including guidance about the navel and skin condition.
A person with limited hand mobility or difficulty seeing the injection area should ask for a demonstration and discuss assistance. The right question is whether the injection can be completed correctly and safely with the actual device. Switching between an Ozempic multidose pen, a Wegovy presentation, and a pharmacy-supplied vial can change the steps substantially. Familiarity with the general body location does not mean the equipment works the same way.
Sources: Ozempic prescribing information · Wegovy prescribing information, including tablets and Wegovy HD
What rotation looks like over several weeks
Rotation concerns the exact spot, not a requirement to abandon a comfortable body area every week. A simple log can record the date, dose, general area, and side so you avoid repeatedly using one small patch of skin. If insulin is also injected, use separate injection sites according to the instructions and never mix the medicines in the same injection.
Inspect the intended area before use and follow the supplied guidance about skin to avoid. A persistent local reaction, increasing pain, or possible infection should be assessed rather than hidden by moving to a different spot. If another person helps, agree on who records completion so both people do not administer a dose. Rotation and dose tracking solve different problems, but one clear record can support both.
Sources: Ozempic prescribing information · Wegovy prescribing information, including tablets and Wegovy HD
Does changing the site reduce nausea or strengthen treatment?
Reports of better appetite suppression or less nausea at one site are personal experiences, not a demonstrated universal rule. Dose escalation, food intake, other medicines, and unrelated illness can also affect symptoms. The labels permit specified sites but do not instruct patients to select one for a guaranteed gastrointestinal advantage.
If symptoms interfere with meals or fluids, describe them to the prescriber rather than conducting a series of site experiments while escalating. If liquid leaks or you are uncertain about delivery, ask the pharmacist before repeating the dose. The amount visible on the skin cannot reliably tell you how much medicine entered the body. Keep the product name, device, prescribed dose, and time of the attempt available so the clinician or pharmacist can give advice about that situation.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information
Sources and evidence
Sources checked October 2, 2026. Prescribing information supports medication facts; provider pages support advertised services. Offers and labels can change.